home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Alina Combine Pharmaceuticals Pvt. Ltd.

SHARESHARESHARE
Alina Combine Pharmaceuticals (Pvt) Ltd is one of Pakistan's premier Pharmaceutical & Veterinary Medicine manufacturing company following strict GMP guidelines. Our pharmaceutical manufacturing unit is well equipped and manned by highly qualified and experienced personnel. Our current range of products includes Water Soluble Powders, Liquids/Solutions, Liquid Injections in the Veterinary Department and a range of Human Pharmaceuticals in the form of Liquids, Tablets, Ointments, and Injections.
SHARESHARESHARE

RELATED NEWS


The combined results from a small-scale randomized human trial and studies in mice suggest that consuming propionate, a common food ingredient that is used widely to prevent mold, increases levels of hormones that are linked with diabetes and obesity. The research, headed by a team at the Harvard T.H. Chan School of Public Health, found that in mice, exposure to low doses of propionate activated the sympathetic nervous system, triggered the production of fasting hormones, leading to insulin resi...

READ MORE

US regulators have issued an accelerated approval for Bayer’s relapsed follicular lymphoma therapy Aliqopa. The decision allows physicians in the country to prescribe the drug to patients who have received at least two prior systemic therapies. Follicular lymphoma is a slow-growing type of non-Hodgkin lymphoma, a cancer of the lymph system, and despite being the most common form of NHL is considered a rare disease with unmet need....

READ MORE

AstraZeneca has announced that pooled analyses of the phase III trials for its kidney disease drug roxadustat confirm the drug’s cardiovascular safety – a good sign for the potential blockbuster that hopes to compete with well-established treatments. Roxadustat, co-developed with FibroGen and Astellas, is a first-in-class HIF-PHI inhibitor for the treatment of anaemia caused by chronic kidney disease (CKD), which affects more than 200 million people worldwide. It is looking to take o...

READ MORE

Eleven therapies, including five targeting rare diseases, have taken a giant leap towards being approved in Europe after winning backing from the European Medicines Agency’s Committee for Medicinal Products for Human Use. Santen’s Verkazia (ciclosporin) has been recommended for severe vernal keratoconjunctivitis (VKC), a rare form of chronic eye allergy that can lead to corneal ulcers and loss of sight, affecting 1 to 3 people out of 10,000 in the European Union. VKC occurs mostly in young child...

READ MORE

The European Commission has approved Eisai/Merck & Co’s Lenvima as a new first-line treatment for liver cancer. Eisai and Merck & Co, known as MSD outside the US, said approval for Lenvima (lenvatinib) came through an open-label phase 3 trial, Reflect, demonstrating a treatment effect on overall survival (OS). It was deemed non-inferior to the standard of care drug, Nexavar (sorafenib). Also, the trial results confirmed that Lenvima showed a significant superiority and clinically m...
FDA
READ MORE

Fifteen years ago Professor Greg Kyle (pictured) was preparing to sell his rural pharmacy. His decision to leave community pharmacy was partly for personal reasons. But he was also disenchanted by what......
PHARMACYNEWS
READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...